Cart
sales@molnova.com
AN3199
CAS No. 1187187-10-5
AN3199( —— )
Catalog No. M32778 CAS No. 1187187-10-5
AN3199 is a selective inhibitor of PDE4 with an IC50 of 94.5 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 5MG | 28 | In Stock |
|
| 10MG | 28 | In Stock |
|
| 25MG | 39 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAN3199
-
NoteResearch use only, not for human use.
-
Brief DescriptionAN3199 is a selective inhibitor of PDE4 with an IC50 of 94.5 nM.
-
DescriptionAN3199 is a PDE4 inhibitor with an IC50 of 94.5 nM. AN3199 can be used for the research of inflammation-associated diseases such as asthma and chronic obstructive pulmonary disease (COPD).
-
In VitroAN3199 (compound 11) (1 h) disappears (98.0%) is mainly converts to corresponding acid (76.6) in mouse plasma.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1187187-10-5
-
Formula Weight327.14
-
Molecular FormulaC17H18BNO5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (305.68 mM; Ultrasonic )
-
SMILESCCCCOC(=O)c1ccc(Oc2ccc3B(O)OCc3c2)nc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang YK, et al. Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2270-4.?
molnova catalog
related products
-
HA-155
HA155 is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine.
-
ONO-6126
ONO-6126 is a potent and selective PDE4 inhibitor for the treatment of bronchial asthma and allergic conjunctivitis.
-
PQ-10
PQ-10 is a PDE-10 inhibitor. PQ-10 induces brain glucose metabolism patterns, which may be a potential translational biomarker.
